Free Trial

Sangamo Therapeutics (SGMO) Insider Trading & Ownership

Sangamo Therapeutics logo
$0.12 +0.01 (+13.75%)
As of 05/8/2026 03:59 PM Eastern

Sangamo Therapeutics (NASDAQ:SGMO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$107.40K
Get SGMO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sangamo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGMO Insider Buying and Selling by Quarter

Sangamo Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/22/2026
Gregory D Davis
Insider
Sell69,827$0.25$17,456.75  
4/21/2026
Nathalie Dubois-Stringfellow
SVP
Sell345,942$0.26$89,944.92  
(Data available from 1/1/2013 forward)

SGMO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sangamo Therapeutics includes Biogen Inc., Gregory D Davis, and Nathalie Dubois-Stringfellow. Learn more on insiders at SGMO.

4.10% of Sangamo Therapeutics stock is owned by insiders. Learn more on SGMO's insider holdings.

The following insiders have sold SGMO shares in the last 24 months: Gregory D Davis ($17,456.75), and Nathalie Dubois-Stringfellow ($89,944.92).

Insiders have sold a total of 415,769 Sangamo Therapeutics shares in the last 24 months for a total of $107,401.67 sold.



This page (NASDAQ:SGMO) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners